Typical unit of plasma manufactured from whole blood
An example of a typical unit of plasma manufactured from whole blood.
Image
Another example of a typical unit of plasma manufactured from whole blood (viewed from the back).
Image
Another example of typical variation of plasma produced from whole blood.
Image
Another example of typical variation of plasma produced from whole blood. Note: Photographed prior to freezing, bubbles are normal at this stage.
Image
Plasma manufactured from whole blood with bacterial contamination
Photo not available.
Image
Typical unit of apheresis plasma
An example of a typical unit of plasma manufactured using apheresis method.
Image
Apheresis plasma with bacterial contamination
Photo not available.
Image
Typical unit of apheresis frozen plasma, psoralen-treated
Photo not available.
Image
Apheresis frozen plasma, psoralen-treated with bacterial contamination
Photo not available.
Image
Bacterial contamination is the presence of bacteria in the blood. Blood should be free of bacteria. Blood is collected and manufactured under sterile conditions to maintain this aseptic state. Bacterially contaminated blood components should NOT be transfused and any components suspected of bacterial contamination based on a visual inspection should be reported to Canadian Blood Services using the feedback form on blood.ca. Contact the nearest distribution centre to report potential contamination and receive further instructions.
Possible (though rare) causes of bacterial contamination include the following:
Donor with asymptomatic bacteremia (i.e., subclinical bacteria in blood)
Inadequate cleansing of skin prior to venipuncture. (Please note: To minimize bacterial contamination, Canadian Blood Services uses a diversion pouch for the first portion of the blood collection. In addition to strict protocol on skin cleansing, the diversion pouch prevents the skin plug and skin bacteria from entering the main unit.)
Loss of sterility during component manufacturing or handling
Of note, pathogen reduction technologies such as psoralen treatment have been introduced into some blood component manufacturing processes to decrease risk of bacterial contamination/infectious risk.
Visual appearance
The presence of bacteria may produce gas resulting in unusual air bubbles.
The presence of bacteria may activate clotting resulting in clots and fibrin strands.
Cloudiness
Image
Plasma units spiked with four bacterial species in a laboratory setting, photographed on Day 0 and Day 6 of cold storage. By Day 6, there were no observable changes in the plasma's appearance for any of the units spiked with bacteria, despite proliferation of two bacterial species (S. liquefaciens and P. fluorescens).